Effect of viral infection on T-cell apoptosis in allograft recipients.
Rancewicz
Z
Z
Transplantation Institute, Warsaw, Poland.
Kasprzycka
M
M
Zagozdzon
R
R
Wierzbicki
P
P
Durlik
M
M
Juskowa
J
J
Górski
A
A
Paczek
L
L
D017209:Apoptosis / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000276:immunology*; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000276:immunology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D016853:Muromonab-CD3 / Q000494:pharmacology; D011183:Postoperative Complications / Q000276:immunology / Q000821:virology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3